Moreover, in systemic NMO mice, anti-CHI3L1 treatment decreased myelin loss, preserved myelinated axons (Figure 2C; assayed by MBP staining), and reduced microgliosis, accompanied by prevention of ventral horn neuronal loss in the lumbar spinal cord (Supplemental Figure 3D). This evidence concerns the gene MBP and neuromyelitis optica.